Medical and Pharmaceutical Eli Lilly funds Indigenous lung health education initiative in North America 'Healthy Workforce, Productive Community' will extend for 3 years Rowan Dunne1 day ago
Medical and Pharmaceutical 60 Degrees Pharma flies after curing tick disease in small-scale study The company is planning an NDA submission for its flagship drug as a Babesiosis treatment Rowan DunneMarch 12, 2026
Medical and Pharmaceutical Acurx Pharma shares rise by 29% on new trial for breakthrough antibiotic ‘ibezapolstat’ Investors are optimistic about the therapeutic's potential as a superior alternative for CDI treatment Rowan DunneMarch 11, 2026
AI and Autonomy Medical revolution: AI bot ‘Delphi-2M’ can predict your risk of over 1,000 diseases It will provide a timeline showing when a person is most likely to develop a condition Rowan DunneSeptember 18, 2025
Psychedelics Scientists coin the term ‘PiPi drugs’: a new frontier in psychedelic medicine Non-psychoactive therapeutics derived from psychedelic compounds have promising anti-inflammatory properties Rowan DunneSeptember 5, 2025
Medical and Pharmaceutical Researchers discover how Alzheimer’s drug could be used to prevent lung cancer spread They found that a protein associated with the neurodegenerative disease helps lung cancer move to the brain Rowan DunneJuly 9, 2025
Medical and Pharmaceutical Breathe BioMedical adds research site to breast cancer breath test study The Canadian company aims to provide an accurate screening measure for women with dense breast tissue Rowan DunneJune 18, 2025
Medical and Pharmaceutical ‘ORACLE’ lung cancer test helps predict survival with superior precision British researchers just published an extensive study on the tissue biopsy in Nature Cancer Rowan DunneJanuary 13, 2025
Science and Research IGM Biosciences slides by 66% on discontinued drug development and lay offs The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis Rowan DunneJanuary 10, 2025
Medical and Pharmaceutical GRAIL uses lung cancer blood test to determine who needs post-surgery therapy most The first patient has been screened with the R&D-stage test in a Phase III study Rowan DunneNovember 19, 2024